BCM Oncology Scholars Training Program

项目摘要/摘要 肿瘤学的转化性研究培训需要一个指导计划 来自多个学科的组件。近几年来，中国一直缺乏 具有临床和实验室研究专长的年轻研究人员。为了 增加翻译领域有才华的内科科学家和博士科学家的队伍 我们需要提高癌症研究的培训机会。BCM肿瘤学学者 培训计划旨在满足医学博士(或医学博士/博士)的需求。和博士学位。 实习生。该计划由五个科研主题组成，包括：(1) “全基因组学”科学(基因组学、蛋白质组学和代谢组学)；(2)癌症信号 途径；(3)干细胞与发育；(4)治疗与诊断；(5)癌症 流行病学和预防。从贝勒血液学/肿瘤学研究员的每个班级， 我们将挑选一名学者，并提供三年的研究支持和指导， 从团契的后半部分开始，一直延伸到前十八个月 初级教员职位。为了培养肿瘤学方面的博士学位，我们将 此外，每年通过以下途径从BCM博士后人才库中挑选一名博士后学者 公开竞争，并支持她/他的癌症翻译研究三年。每个人 学者实习生将接受包括教学在内的肿瘤学研究培训计划 课程、职业发展技能和有指导的实验室研究。每个实习生都将 接受针对学员特定兴趣而量身定做的指导。通过联合- 医学博士和博士研究生在研究导师和临床导师之间的指导 教职员工和特定于项目的研究研讨会系列，拟议的T32将作为 一个为我们的实习生开发翻译癌症协作研究的平台，并 培养他们的职业发展。

Project Summary/Abstract Translational research training in oncology requires a mentoring program with components from multiple disciplines. In recent years, there has been a shortage of young investigators with both clinical and laboratory research expertise. In order to increase the pool of talented physician-scientists and Ph.D. scientists in translational cancer research we need to improve training opportunities. The BCM Oncology Scholars Training Program aims to address the needs of both M.D. (or M.D./Ph.D.) and Ph.D. trainees. The program is composed of five scientific research themes including: (1) "Omics" sciences (genomics, proteomics and metabolomics); (2) Cancer signaling pathways; (3) Stem cells and development; (4) Therapeutics and diagnostics; (5) Cancer epidemiology and prevention. From each class of Baylor hematology/oncology fellows, we will select a scholar and provide three years of research support and mentoring, starting in the second half of the fellowship and extending into the first eighteen months of a junior faculty position. To train Ph.D. the translational research in oncology, we will also select a Ph.D. postdoctoral scholar each year from the BCM postdoctoral pool via open competition and support her/his translational cancer research for three years. Each scholar trainee will receive a training program in oncological research including didactic courses, career development skills and mentored laboratory research. Each trainee will receive mentorship tailored to the specific interests of the trainees. Through co- mentorship for the M.D. and Ph.D. scholars between research mentors and clinical faculty, and a program-specific research seminar series, the proposed T32 will serve as a platform to develop translational cancer collaborative research for our trainees and to nurture their career development.